Basic Information
Basic information for LINC01278-213-26aa
Peptide Name LINC01278-213-26aa
Genome Position chrX:63428684-63428761[-]
Species Human
Peptide Sequence MLAQTALFCRPLPFYKLVRVENSTRA
Peptide Length 26
Unique No (LINC01278-202-26aa,LINC01278-204-26aa,LINC01278-205-26aa,LINC01278-209-26aa,LINC01278-219-26aa,LINC01278-225-26aa,LINC01278-226-26aa,LINC01278-232-26aa,LINC01278-235-26aa,LINC01278-238-26aa)
Grand Average of Hydropathicity 0.1692
Relative Molecular Mass 3476.05
Experimental Evidences 2:m6A,ribo
lncRNA ID/Name ENSG00000235437;LINC01278
Transcript ID/Name ENST00000656972;LINC01278-213
Transcript Length 2952
Coding Ability 0.4695
DNA Sequence Corresponding to Peptide ATGTTAGCCCAAACTGCACTATTTTGCAGACCCCTACCATTTTACAAACTGGTCAGAGTGGAAAATTCCACCAGGGCC
Experimental Evidences
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :